Cargando…
Are Gastroenterologists Less Tolerant of Treatment Risks than Patients? Benefit-Risk Preferences in Crohn's Disease Management
BACKGROUND: Crohn's disease is a serious and debilitating gastrointestinal disorder with a high, unmet need for new treatments. Biologic agents have the potential to alter the natural course of Crohn's disease but present known risks of potential serious adverse events (SAEs). Previous stu...
Autores principales: | Johnson, F. Reed, Hauber, Brett, Siegel, Corey A., Hass, Steven, Sands, Bruce E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438243/ https://www.ncbi.nlm.nih.gov/pubmed/20866166 http://dx.doi.org/10.18553/jmcp.2010.16.8.616 |
Ejemplares similares
-
Physician and patient benefit–risk preferences from two randomized long-acting injectable antipsychotic trials
por: Katz, Eva G, et al.
Publicado: (2016) -
Patients with IBD Want to Talk About Sleep and Treatments for Insomnia with Their Gastroenterologist
por: Salwen-Deremer, Jessica K., et al.
Publicado: (2023) -
Gastroenterologists’ Views of Shared Decision Making for Patients with Inflammatory Bowel Disease
por: Siegel, Corey A., et al.
Publicado: (2015) -
Benefit of “transparent soft-short-hood on the scope” for colonoscopy among experienced gastroenterologists and gastroenterologist trainee: a randomized, controlled trial
por: Prachayakul, Varayu, et al.
Publicado: (2011) -
Assessing gastroenterologist and patient acceptance of biosimilars in ulcerative colitis and Crohn's disease across Germany
por: Sullivan, Emma, et al.
Publicado: (2017)